DV Biomed Co., Ltd. (TPEX:6539)
Taiwan
· Delayed Price · Currency is TWD 49.40
0.00 (0.00%)
Apr 29, 2026, 1:45 PM CST
DV Biomed Revenue
In the year 2025, DV Biomed had annual revenue of 794.18M TWD with 38.46% growth. DV Biomed had revenue of 406.43M in the half year ending December 31, 2025, with 38.49% growth.
Revenue
794.18M
Revenue Growth
+38.46%
P/S Ratio
1.51
Revenue / Employee
2.44M
Employees
326
Market Cap
1.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 794.18M | 220.60M | 38.46% |
| Dec 31, 2024 | 573.57M | -45.28M | -7.32% |
| Dec 31, 2023 | 618.85M | -1.25B | -66.84% |
| Dec 31, 2022 | 1.87B | 38.99M | 2.13% |
| Dec 31, 2021 | 1.83B | 15.42M | 0.85% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Excelsior Biopharma | 898.26M |
| Winston Medical Supply | 700.07M |
| Prince Pharmaceutical | 1.06B |
| Anxo Pharmaceutical | 883.22M |
| Original BioMedicals | 381.00K |
| Mediera | 229.85M |
| GeneFerm Biotechnology | 677.10M |
| InnoPharmax | 68.99M |